Reference : Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmo...
Scientific journals : Article
Life sciences : Genetics & genetic processes
Systems Biomedicine
http://hdl.handle.net/10993/32534
Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features
English
Niturad, Elena Christina []
Lev, Dorit []
Kalscheuer, Vera M []
Charzewska, Agnieszka []
Schubert, Julian []
Lerman-Sagie, Tally []
Kroes, Hester Y []
Oegema, Renske []
Traverso, Monica []
Specchio, Nicola []
Lassota, Maria []
Chelly, Jamel []
Bennett-Back, Odeya []
Carmi, Nirit []
Koffler-Brill, Tal []
Iacomino, Michele []
Trivisano, Marina []
Capovilla, Giuseppe []
Striano, Pasquale []
Nawara, Magdalena []
Rzonca, Sylwia []
Fischer, Ute []
Bienek, Melanie []
Jensen, Corinna []
Hu, Hao []
Thiele, Holger []
Altmüller, Janine []
Krause, Roland mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
May, Patrick mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Becker, Felicitas []
EuroEPINOMICS Consortium []
Balling, Rudi mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Biskup, Saskia []
Haas, Stefan A []
Nürnberg, Peter []
van Gassen, Koen L I []
Lerche, Holger []
Zara, Federico []
Maljevic, Snezana []
Leshinsky-Silver, Esther []
1-Nov-2017
Brain : A Journal of Neurology
Oxford University Press
140
11
2879-2894
Yes (verified by ORBilu)
International
0006-8950
1460-2156
Oxford
United Kingdom
[en] Epilepsy ; GABRA3 ; Seizures ; X-linked disease ; intellectual disability ; neuronal inhibition
[en] Genetic epilepsies are caused by mutations in a range of different genes, many of them encoding ion channels, receptors or transporters. While the number of detected variants and genes increased dramatically in the recent years, pleiotropic effects have also been recognized, revealing that clinical syndromes with various degrees of severity arise from a single gene, a single mutation, or from different mutations showing similar functional defects. Accordingly, several genes coding for GABAA receptor subunits have been linked to a spectrum of benign to severe epileptic disorders and it was shown that a loss of function presents the major correlated pathomechanism. Here, we identified six variants in GABRA3 encoding the α3-subunit of the GABAA receptor. This gene is located on chromosome Xq28 and has not been previously associated with human disease. Five missense variants and one microduplication were detected in four families and two sporadic cases presenting with a range of epileptic seizure types, a varying degree of intellectual disability and developmental delay, sometimes with dysmorphic features or nystagmus. The variants co-segregated mostly but not completely with the phenotype in the families, indicating in some cases incomplete penetrance, involvement of other genes, or presence of phenocopies. Overall, males were more severely affected and there were three asymptomatic female mutation carriers compared to only one male without a clinical phenotype. X-chromosome inactivation studies could not explain the phenotypic variability in females. Three detected missense variants are localized in the extracellular GABA-binding NH2-terminus, one in the M2-M3 linker and one in the M4 transmembrane segment of the α3-subunit. Functional studies in Xenopus laevis oocytes revealed a variable but significant reduction of GABA-evoked anion currents for all mutants compared to wild-type receptors. The degree of current reduction correlated partially with the phenotype. The microduplication disrupted GABRA3 expression in fibroblasts of the affected patient. In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern.
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) ; Luxembourg Centre for Systems Biomedicine (LCSB): Experimental Neurobiology (Balling Group)
http://hdl.handle.net/10993/32534
10.1093/brain/awx236

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
awx236.pdfPublisher postprint1.1 MBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.